 Sequences taxol cisplatin phase study solid tumor patients sequences taxol cisplatin Sequential dose escalation agent taxol doses cisplatin doses dosage permutations grades neutropenia courses Neutropenia brief hospitalization neutropenia fever courses escalation taxol grade neutropenia courses taxol-cisplatin dose level mean neutrophil count nadir hospitalization neutropenia fever courses sequence cisplatin taxol antitumor activity vitro profound alternate sequence Pharmacologic studies difference due taxol clearance rates cisplatin taxol neurotoxicity serious effect combination modest neurotoxicity patients Adverse effects myalgias alopecia diarrhea bradycardia asymptomatic ventricular tachycardia Objective responses melanoma non-small-cell lung ovarian breast head neck colon pancreatic carcinomas results sequence taxol cisplatin doses phase II/III trials escalation taxol treatment